Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Controlled Phase 2 Study of Fibrin Sealant FS VH S/D 500 s-apr for Hemostasis in Hepatic Resection
2010-018480-42Phase 2Completed
- Sponsor
- Baxter International Inc.
- Start
- Jul 2010
- Modality
- Recombinant Proteins and Enzymes, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised trial of tisseel in Not applicable (2 arms), sponsored by Baxter International Inc. Primary endpoint: Intraoperative hemostasis at 4 minutes. Started Jul 2010; status: completed.
02
Drugs
tisseel
03
Conditions
Not applicable
Beyond the preview
Go deeper on 2010-018480-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018480-42.